Q3 2023 · 13F-HR
BROADWOOD CAPITAL INCholdings as filed
Filed 2023-11-14 · accession 0000919574-23-006249
$1.12B
Reported value
7
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 61174X109 | MNST | MONSTER BEVERAGE CORP NEW | $450.1M | 40.0% | 8,501,236 | Common | SOLE |
| 852312305 | STAA | STAAR SURGICAL CO | $372.2M | 33.1% | 9,264,427 | Common | SOLE |
| 05464C101 | AXON | AXON ENTERPRISE INC | $151.2M | 13.4% | 760,062 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $100.0M | 8.89% | 566,000 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS INC | $41.2M | 3.67% | 34,935,485 | Common | SOLE |
| 68235C206 | IMDX | ONCOCYTE CORP | $7.8M | 0.70% | 2,509,066 | Common | SOLE |
| 00848H108 | AGEGBP | AGEX THERAPEUTICS INC | $2.0M | 0.18% | 2,997,156 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.